Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Am J Clin Oncol. 2015 Oct;38(5):442–447. doi: 10.1097/COC.0b013e3182a46896

FIGURE 1.

FIGURE 1

Schematic depiction of crizotinib-mediated endocrine disruption. FSH indicates follicle stimulating hormone; GH, growth hormone; IGF-1, insulin-like growth factor-1; IGF-R, insulin-like growth factor receptor; LH, luteinizing hormone; PRL-R, prolactin receptor.